BioVid is a forward-thinking biotechnology company committed to revolutionizing healthcare through the development of groundbreaking diagnostic tools and therapeutic solutions. We leverage cutting-edge research in genomics, proteomics, and data science to address complex diseases. Our focus is on translating scientific discoveries into tangible products that improve patient outcomes and enhance quality of life. BioVid fosters a culture of innovation, collaboration, and scientific rigor, aiming to be at the forefront of medical advancements.
The headquarters serves as the central hub for research and development, corporate strategy, global operations management, and administrative functions.
State-of-the-art laboratory facilities equipped with advanced sequencing and imaging technologies, collaborative open-concept workspaces, and a dedicated bioinformatics center.
A dynamic and collaborative environment that encourages intellectual curiosity, cross-functional teamwork, and a patient-centric approach. Employees experience a culture of continuous learning and innovation.
Its location in the Bay Area provides access to a rich talent pool, leading academic institutions, research collaborators, and venture capital, fostering growth and innovation.
BioVid operates globally with key functions distributed across its headquarters in California and regional offices in the UK and Singapore. This allows us to support international research collaborations, conduct multi-center clinical trials, manage a global supply chain, and engage with diverse healthcare markets worldwide.
123 Genome Way
South San Francisco
CA
USA
Address: 789 BioPark Avenue, Granta Park
To manage and expand BioVid's clinical research programs in Europe, navigate EU regulatory pathways, and build strategic partnerships within the region.
Address: Biopolis Hub, #05-10 Matrix Building
To facilitate BioVid's expansion into APAC markets, coordinate regional logistics, and tap into the growing research capabilities and diverse patient populations in Asia.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, BioVid' leadership includes:
BioVid has been backed by several prominent investors over the years, including:
Over the past year, BioVid strategically expanded its executive team with key appointments to bolster its clinical and operational capabilities, with no significant executive departures.
Discover the tools BioVid uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
BioVid commonly uses the email format of the first initial followed by the last name. For example, Jane Doe would be jdoe@biovid.com.
[first_initial][last]@biovid.com
Format
athorne@biovid.com
Example
90%
Success rate
BioTech Wire • March 15, 2024
BioVid announced today that its lead investigational drug, BV-701, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of early-stage Alzheimer's disease. This designation facilitates development and expedites the review of drugs to treat serious conditions and fill an unmet medical need....more
Global Pharma News • November 08, 2023
BioVid showcased promising results from its Phase 1b study of an AI-enhanced diagnostic platform for identifying early-stage pancreatic cancer. The data, presented at the European Society for Medical Oncology (ESMO) Congress, demonstrated high accuracy and potential for significant clinical impact....more
VentureBeat LifeSciences • July 20, 2023
BioVid successfully closed a $75 million Series C financing round co-led by Catalyst Ventures and Helix Capital Partners. The proceeds will be used to advance its lead therapeutic candidates into later-stage clinical trials and further develop its proprietary drug discovery platform....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including BioVid, are just a search away.